Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
EClinicalMedicine
.
2022 Jul:49:101493.
doi: 10.1016/j.eclinm.2022.101493.
Epub 2022 Jun 3.
Authors
Peter J Richardson
1
,
Justin Stebbing
2
Affiliations
1
Benevolent AI, Maple Street, London.
2
Department of Surgery and Cancer, Imperial College, London.
PMID:
35692219
PMCID:
PMC9165526
DOI:
10.1016/j.eclinm.2022.101493
No abstract available